nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A collaborative study to establish the 1st International Standard for factor XIII plasma
|
RAUT, S. |
|
2007 |
5 |
9 |
p. 1923-1929 |
artikel |
2 |
A comparison of the associations between seven hemostatic or inflammatory variables and coronary heart disease
|
WOODWARD, M. |
|
2007 |
5 |
9 |
p. 1795-1800 |
artikel |
3 |
A genetic basis for the interrelation of coagulation factors
|
VOSSEN, C. Y. |
|
2007 |
5 |
9 |
p. 1930-1935 |
artikel |
4 |
Altered fibrin clot structure in patients with advanced coronary artery disease: a role of C-reactive protein, lipoprotein(a) and homocysteine
|
UNDAS, A. |
|
2007 |
5 |
9 |
p. 1988-1990 |
artikel |
5 |
ANNOUNCEMENTS
|
|
|
2007 |
5 |
9 |
p. 1996 |
artikel |
6 |
Antiphospholipid syndrome: new light comes from in vivo studies
|
FORASTIERO, R. |
|
2007 |
5 |
9 |
p. 1825-1827 |
artikel |
7 |
Atherothrombosis risk factors: too many and too little
|
EMMERICH, J. |
|
2007 |
5 |
9 |
p. 1793-1794 |
artikel |
8 |
Binding of factor VIIa to the endothelial cell protein C receptor reduces its coagulant activity
|
LÓPEZ-SAGASETA, J. |
|
2007 |
5 |
9 |
p. 1817-1824 |
artikel |
9 |
Challenges in defining type 2M von Willebrand disease: results from a Canadian cohort study
|
JAMES, P. D. |
|
2007 |
5 |
9 |
p. 1914-1922 |
artikel |
10 |
Characterization of the interaction between von Willebrand factor and osteoprotegerin
|
SHAHBAZI, S. |
|
2007 |
5 |
9 |
p. 1956-1962 |
artikel |
11 |
CORRIGENDA
|
|
|
2007 |
5 |
9 |
p. 1995 |
artikel |
12 |
CORRIGENDA
|
|
|
2007 |
5 |
9 |
p. 1995 |
artikel |
13 |
Current practise of testing for inherited thrombophilia
|
COPPENS, M. |
|
2007 |
5 |
9 |
p. 1979-1981 |
artikel |
14 |
Different methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patients
|
PANICCIA, R. |
|
2007 |
5 |
9 |
p. 1839-1847 |
artikel |
15 |
Effect of daptomycin on prothrombin time and the requirement for outlier exclusion in International Sensitivity Index calibration of thromboplastin
|
VAN DEN BESSELAAR, A. M. H. P. |
|
2007 |
5 |
9 |
p. 1975-1976 |
artikel |
16 |
Effect of leg exercises on popliteal venous blood flow during prolonged immobility of seated subjects: implications for prevention of travel-related deep vein thrombosis
|
HITOS, K. |
|
2007 |
5 |
9 |
p. 1890-1895 |
artikel |
17 |
Efficacy of inferior vena cava filters in anticoagulated patients
|
BILLETT, H. H. |
|
2007 |
5 |
9 |
p. 1848-1853 |
artikel |
18 |
Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison
|
TURPIE, A. G. G. |
|
2007 |
5 |
9 |
p. 1854-1861 |
artikel |
19 |
High expression reduces an antibody response after neonatal gene therapy with B domain-deleted human factor VIII in mice
|
XU, L. |
|
2007 |
5 |
9 |
p. 1805-1812 |
artikel |
20 |
Influence of age on the cost-effectiveness of diagnostic strategies for suspected pulmonary embolism
|
RIGHINI, M. |
|
2007 |
5 |
9 |
p. 1869-1877 |
artikel |
21 |
Influence of argatroban on coagulation parameters in heparin-induced thrombocytopenia patients after cardiothoracic surgery
|
HARDER, S. |
|
2007 |
5 |
9 |
p. 1982-1984 |
artikel |
22 |
Influence of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 gene polymorphisms on tissue-type plasminogen activator-induced recanalization in ischemic stroke patients
|
FERNANDEZ-CADENAS, I. |
|
2007 |
5 |
9 |
p. 1862-1868 |
artikel |
23 |
Mg2+ binding to the Gla domain of factor X influences the interaction with tissue factor
|
PERSSON, E. |
|
2007 |
5 |
9 |
p. 1977-1978 |
artikel |
24 |
Multiple roles of the endothelial cell protein C receptor
|
CRAWLEY, J. T. B. |
|
2007 |
5 |
9 |
p. 1813-1816 |
artikel |
25 |
Neonatal immune tolerance for hemophilia: can we ‘tolerate’ new paradigms for gene therapy trials?
|
MONAHAN, P. E. |
|
2007 |
5 |
9 |
p. 1801-1804 |
artikel |
26 |
Once-daily enoxaparin in pediatric thromboembolism: a dose finding and pharmacodynamics/pharmacokinetics study 1
|
O’BRIEN, S. H. |
|
2007 |
5 |
9 |
p. 1985-1987 |
artikel |
27 |
Outcome of the subsequent pregnancy after a first loss in women with factor V Leiden or prothrombin 20210A mutation: a rebuttal
|
LISSALDE-LAVIGNE, G. |
|
2007 |
5 |
9 |
p. 1990-1992 |
artikel |
28 |
Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin 20210A mutation: reply to a rebuttal
|
COPPENS, M. |
|
2007 |
5 |
9 |
p. 1992-1994 |
artikel |
29 |
Platelet function, antiplatelet therapy and clinical outcomes: to test or not to test?
|
DE GAETANO, G. |
|
2007 |
5 |
9 |
p. 1835-1838 |
artikel |
30 |
Prevention of catheter-related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo-controlled study
|
NIERS, T. M. H. |
|
2007 |
5 |
9 |
p. 1878-1882 |
artikel |
31 |
Proteomic analysis of platelet α-granules using mass spectrometry
|
MAYNARD, D. M. |
|
2007 |
5 |
9 |
p. 1945-1955 |
artikel |
32 |
Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors
|
KONKLE, B. A. |
|
2007 |
5 |
9 |
p. 1904-1913 |
artikel |
33 |
Revised classification criteria for antiphospholipid syndrome and the thrombotic risk in patients with autoimmune diseases
|
SWADŹBA, J. |
|
2007 |
5 |
9 |
p. 1883-1889 |
artikel |
34 |
Role of p38 mitogen-activated protein kinase in antiphospholipid antibody-mediated thrombosis and endothelial cell activation
|
VEGA-OSTERTAG, M. E. |
|
2007 |
5 |
9 |
p. 1828-1834 |
artikel |
35 |
Scientific and standardization committee communications: classification and nomenclature of disintegrins isolated from snake venoms
|
MCLANE, M. A. |
|
2007 |
5 |
9 |
p. 1971 |
artikel |
36 |
Scott syndrome dogs have impaired coated-platelet formation and calcein-release but normal mitochondrial depolarization
|
BROOKS, M. B. |
|
2007 |
5 |
9 |
p. 1972-1974 |
artikel |
37 |
Systemic administration of anti-urokinase plasminogen activator receptor monoclonal antibodies induces hepatic fibrin deposition in tissue-type plasminogen activator deficient mice
|
JÖGI, A. |
|
2007 |
5 |
9 |
p. 1936-1944 |
artikel |
38 |
The cost-effectiveness of warfarin pharmacogenomics
|
VEENSTRA, D. L. |
|
2007 |
5 |
9 |
p. 1974-1975 |
artikel |
39 |
The plasma kallikrein–kinin system and risk of cardiovascular disease in men
|
GOVERS-RIEMSLAG, J. W. P. |
|
2007 |
5 |
9 |
p. 1896-1903 |
artikel |
40 |
Two novel monoclonal antibodies to VWFA3 inhibit VWF-collagen and VWF-platelet interactions
|
ZHAO, Y. |
|
2007 |
5 |
9 |
p. 1963-1970 |
artikel |